Phase 3 Limb Ischemia Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
Thrombolysis With Recombinant Non-immunogenic Staphylokinase vs Surgery in Patients With Acute Limb Ischemia FORAT Trial
Acute Limb Ischemia
Supergene, LLC170 enrolled8 locationsNCT05372718
Recruiting
Phase 3
Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee
Peripheral Artery DiseaseCritical Limb Ischemia
Mercator MedSystems, Inc.250 enrolled2 locationsNCT04433572
Recruiting
Phase 3
Trial to Assess Chelation Therapy in Critical Limb Ischemia
DiabetesCritical Limb Ischemia
Mt. Sinai Medical Center, Miami50 enrolled1 locationNCT03982693